Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Company Information
About this company
Key people
John L. Erb
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Carisa Schultz
Chief Financial Officer
Neil P. Ayotte
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Katharyn Field
Independent Director
Archelle Georgiou
Independent Director
Mika Grasso
Independent Director
Gregory D. Waller
Independent Director
Click to see more
Key facts
- Shares in issue1.69m
- EPICNUWE
- ISINUS67113Y7022
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap$5.09m
- Employees38
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.